41 related articles for article (PubMed ID: 19189401)
1. Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor.
Saito Y; Yasunaga M; Kuroda J; Koga Y; Matsumura Y
Cancer Sci; 2008 Jun; 99(6):1258-64. PubMed ID: 18429960
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
Sasaki T; Watanabe J; He X; Katagi H; Suri A; Ishi Y; Abe K; Natsumeda M; Frey WH; Zhang P; Hashizume R
J Neurosurg; 2023 Jun; 138(6):1570-1579. PubMed ID: 36599085
[TBL] [Abstract][Full Text] [Related]
3. Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model.
Tseng YY; Yang TC; Chen SM; Yang ST; Tang YL; Liu SJ
Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32456305
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
Hamaguchi T; Tsuji A; Yamaguchi K; Takeda K; Uetake H; Esaki T; Amagai K; Sakai D; Baba H; Kimura M; Matsumura Y; Tsukamoto T
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1021-1029. PubMed ID: 30284603
[TBL] [Abstract][Full Text] [Related]
5. Development of bioactive materials for glioblastoma therapy.
Yang J; Li Y; Zhang T; Zhang X
Bioact Mater; 2016 Sep; 1(1):29-38. PubMed ID: 29744393
[TBL] [Abstract][Full Text] [Related]
6. A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative.
Inoue Y; Hibino M; Murata I; Kanamoto I
Pharm Res; 2017 Dec; 35(1):1. PubMed ID: 29285607
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling prodrugs.
Cheetham AG; Chakroun RW; Ma W; Cui H
Chem Soc Rev; 2017 Oct; 46(21):6638-6663. PubMed ID: 29019492
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model.
Takashima H; Tsuji AB; Saga T; Yasunaga M; Koga Y; Kuroda JI; Yano S; Kuratsu JI; Matsumura Y
Sci Rep; 2017 Sep; 7(1):12341. PubMed ID: 28951589
[TBL] [Abstract][Full Text] [Related]
9. Clinical Translation of Nanomedicine.
Min Y; Caster JM; Eblan MJ; Wang AZ
Chem Rev; 2015 Oct; 115(19):11147-90. PubMed ID: 26088284
[No Abstract] [Full Text] [Related]
10. Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.
Vejjasilpa K; Nasongkla N; Manaspon C; Larbcharoensub N; Boongird A; Hongeng S; Israsena N
Exp Biol Med (Maywood); 2015 Dec; 240(12):1640-7. PubMed ID: 26080460
[TBL] [Abstract][Full Text] [Related]
11. Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.
Choi SA; Lee YE; Kwak PA; Lee JY; Kim SS; Lee SJ; Phi JH; Wang KC; Song J; Song SH; Joo KM; Kim SK
Cancer Gene Ther; 2015 Jun; 22(6):302-11. PubMed ID: 26021486
[TBL] [Abstract][Full Text] [Related]
12. The potential of polymeric micelles in the context of glioblastoma therapy.
Morshed RA; Cheng Y; Auffinger B; Wegscheid ML; Lesniak MS
Front Pharmacol; 2013 Dec; 4():157. PubMed ID: 24416018
[TBL] [Abstract][Full Text] [Related]
13. Poly(ε-caprolactone)-block-poly(ethyl ethylene phosphate) micelles for brain-targeting drug delivery: in vitro and in vivo valuation.
Zhang P; Hu L; Wang Y; Wang J; Feng L; Li Y
Pharm Res; 2010 Dec; 27(12):2657-69. PubMed ID: 20848303
[TBL] [Abstract][Full Text] [Related]
14. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
Trivedi R; Kompella UB
Nanomedicine (Lond); 2010 Apr; 5(3):485-505. PubMed ID: 20394539
[TBL] [Abstract][Full Text] [Related]
15. Cancer therapies utilizing the camptothecins: a review of the in vivo literature.
Venditto VJ; Simanek EE
Mol Pharm; 2010 Apr; 7(2):307-49. PubMed ID: 20108971
[TBL] [Abstract][Full Text] [Related]
16. Pegylated phospholipids-based self-assembly with water-soluble drugs.
Wang Y; Wang R; Lu X; Lu W; Zhang C; Liang W
Pharm Res; 2010 Feb; 27(2):361-70. PubMed ID: 20033475
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.
Kuroda J; Kuratsu J; Yasunaga M; Koga Y; Saito Y; Matsumura Y
Int J Cancer; 2009 Jun; 124(11):2505-11. PubMed ID: 19189401
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of NK012, a 7-ethyl-10-hydroxycamptothecin-incorporating polymeric micelle, on U87MG orthotopic glioblastoma in mice compared with irinotecan hydrochloride in combination with bevacizumab.
Kuroda J; Kuratsu J; Yasunaga M; Koga Y; Kenmotsu H; Sugino T; Matsumura Y
Clin Cancer Res; 2010 Jan; 16(2):521-9. PubMed ID: 20068081
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan.
Nakajima TE; Yanagihara K; Takigahira M; Yasunaga M; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Mihara K; Ochiya T; Matsumura Y
Cancer Res; 2008 Nov; 68(22):9318-22. PubMed ID: 19010905
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
